The Purinergic Ligand‐Gated Ion Channel 7 Receptor Promotes the Proliferation, Invasion, and Migration of Breast Cancer Cells
Authors:
- 19 February 2025
- journal article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 39 (2) , e70184
Abstract
Purinergic ligand‐gated ion channel 7 receptor (P2X7R) has essential functions in tumor proliferation, apoptosis, metastasis, and invasion, and the purpose of this study was to explore the effects of P2X7R on the biological behaviors of MCF‐7 and MDA‐MB‐231 cells. A bioinformatics analysis of P2X7R expression in breast cancer was performed and its relationships with overall survival and immune cell infiltration were determined. P2X7R ion channel function was detected via a Fluo‐4‐AM assay. Proliferation, migration and invasion were investigated using CCK‐8, scratch wound healing, and Transwell assays, respectively. The levels of P2X7R, JNK, p‐JNK, Akt, p‐Akt, E‐cadherin, N‐cadherin, vimentin and GAPDH were detected by western blotting. The role of P2X7R on the biological behaviors of MCF‐7 cells was detected in vivo. Bioinformatics analysis revealed an obvious increase in the expression of P2X7R in breast cancer and differences were observed among the different subtypes. High expression of P2X7R was negatively correlated with overall survival and affected immune cell infiltration. The experimental results revealed that both types of cells express functional P2X7R. ATP and BzATP can promote proliferation, invasion, and metastasis after P2X7R activation; upregulate p‐Akt, p‐JNK, N‐cadherin and vimentin; and downregulate E‐cadherin compared with the control group, and the addition of the antagonist A438079 or oxATP or the knockdown of P2X7R could weaken these effects. The activation of P2X7R in breast cancer cells can promote their biological behaviors, indicating that P2X7R is a latent therapeutic target in breast cancer.Keywords
This publication has 57 references indexed in Scilit:
- TBL2 Promotes Tumorigenesis via PRMT5/WDR77‐Mediated AKT Activation in Breast CancerAdvanced Science, 2024
- Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathwayScience China Life Sciences, 2024
- P2 purinergic receptors regulate the progression of colorectal cancerPurinergic Signalling, 2023
- P2X receptors in cancer growth and progressionBiochemical Pharmacology, 2021
- P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomasPurinergic Signalling, 2020
- Production, characterization, and application of a monoclonal antibody specific for the extracellular domain of human P2X7RApplied Microbiology and Biotechnology, 2020
- Highly‐expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β‐catenin and mTOR/HIF1α/VEGF signalingInternational Journal of Cancer, 2019
- Regulation of the P2X7R by microRNA-216b in human breast cancerBiochemical and Biophysical Research Communications, 2014
- Purinergic signalling and cancerPurinergic Signalling, 2013
- Extracellular ATP and Cancer—An Overview with Special Reference to P2 Purinergic ReceptorsPathology and Oncology Research, 2008